
Opinion|Videos|April 30, 2025
Conversations About Off Time In Patients With Parkinson Disease
Panelists discuss how physicians approach conversations about off time with patients with Parkinson disease, balancing clinical assessment with patient education and shared decision-making.
Advertisement
Episodes in this series

Video content above is prompted by the following:
Physician-Patient Communication About Off Time
- Structured assessment using validated tools (Movement Disorder Society (MDS), Unified Parkinson's Disease Rating (UPDRS), Wearing Off Questionnaire-9 (WOQ-9), Hauser Diary)
- Dedicated time to discuss daily symptom patterns and medication response
- Use of accessible language and visual aids to explain pharmacokinetics
- Involvement of caregivers to provide collateral information
- Setting realistic expectations about treatment goals
- Shared decision-making approach to treatment selection
- Regular follow-up with focused reassessment of off time
- Discussion of impact on quality of life and function, not just motor symptoms
- Education about differentiating off symptoms from nonmotor manifestations
Newsletter
Keep your finger on the pulse of neurology—subscribe to NeurologyLive for expert interviews, new data, and breakthrough treatment updates.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
FDA Approves Inebilizumab for AChR- and MuSK-Positive Generalized Myasthenia Gravis
2
NDA Accepted for Narcolepsy Oxybate TRN-257, Gene Therapy ETX101 Early Promise in Dravet, Bexicaserin's Impact on Developmental Encephalopathies
3
FDA Clears Pivotal Phase 3 PREVAiLS Study of Pridopidine in Early, Rapidly Progressive ALS
4
FDA Action Update, November 2025: Approvals, Clearance, and Boxed Warning
5
































